背景:结缔组织病(CTD)是一组异质性的慢性炎症性自身免疫性疾病,源于系统性自身免疫失调。CTD可能通过多种病理生理机制影响心脏结构,亚临床心脏损伤较为常见。心力衰竭(HF)是这些患者的常见并发症之一。
方法:CTD患者患心血管疾病的风险增加,可能有胸痛和呼吸急促。
方法:HF的特征是由于心室充盈和/或血液射血受损而导致的呼吸困难或劳力受限。HF可由其他全身性疾病引起,不仅是心血管疾病,还有CTD。CTD可能由于弥漫性心肌损伤而引起HF,心脏瓣膜损伤,冠状动脉缺血,等等。
方法:灾难性抗磷脂综合征患者服用泼尼松和华法林。抗合成酶综合征患者接受免疫球蛋白治疗,其次是强的松的长期口服药物,甲氨蝶呤,和叶酸。
结果:CTD患者的胸痛和呼吸急促症状得到改善。
结论:HF是这些CTD患者的常见并发症之一,预后不良,病情严重加重。一旦这些患者出现胸痛,胸闷,呼吸急促,etc,我们应该考虑HF的可能性。早期识别和正确治疗可以延缓HF的进展,改善预后,提高患者的生活质量。因此,CTD合并HF患者应引起重视。
BACKGROUND: Connective tissue disease (CTD) is a heterogeneous group of chronic inflammatory autoimmune disorders derived from a systemically auto-immunological deregulation. CTD may affect cardiac structures through multiple pathophysiological mechanisms, and subclinical cardiac injury is common. Heart failure (HF) is one of the common complications in these patients.
METHODS: Patients with CTD suffer an increased risk of cardiovascular disease and may have chest pain and shortness of breath.
METHODS: HF is characterized by dyspnea or exertional limitation due to impaired ventricular filling and/or blood ejection. HF can be caused by other systemic diseases, not only by cardiovascular disorders but CTD. CTD may cause HF due to diffuse myocardial damage, heart valve damage, coronary ischemia, and so on.
METHODS: The patient with catastrophic antiphospholipid syndrome take prednisone and warfarin. The patient with anti-synthetase syndrome was treated with immunoglobulin, followed by long-term oral medicines of prednisone, methotrexate, and folic acid.
RESULTS: The symptoms of chest pain and shortness of breath for patients with CTD improved.
CONCLUSIONS: HF is one of the common complications in these patients with CTD, which has poor prognosis and severe aggravation. Once such patients experience chest pain, chest tightness, shortness of breath, etc, we should consider the possibility of HF. Early identification and correct treatment can delay the progression of HF, improve the prognosis, and enhance the quality of life for patients. Therefore, we should pay more attention to patients with CTD combined with HF.